Functional Dichotomy between OX40 and 4-1BB in Modulating Effector CD8 T Cell Responses1
暂无分享,去创建一个
B. Kwon | M. Croft | H. Cheroutre | Yunji Park | Seung-Woo Lee | A. Song
[1] B. Kwon,et al. Costimulation of mast cells by 4-1BB, a member of the tumor necrosis factor receptor superfamily, with the high-affinity IgE receptor. , 2005, Blood.
[2] M. Ostrowski,et al. Enhancement of HIV-Specific CD8 T Cell Responses by Dual Costimulation with CD80 and CD137L1 , 2005, The Journal of Immunology.
[3] Yu Wang,et al. TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand , 2005, The Journal of experimental medicine.
[4] Tomoko Yamaguchi,et al. Engagement of 4-1BB Inhibits the Development of Experimental Allergic Conjunctivitis in Mice1 , 2005, The Journal of Immunology.
[5] M. Croft,et al. OX40 and Bcl-xL Promote the Persistence of CD8 T Cells to Recall Tumor-Associated Antigen1 , 2005, The Journal of Immunology.
[6] D. Kelvin,et al. The expression and the regulatory role of OX40 and 4-1BB heterodimer in activated human T cells. , 2005, Blood.
[7] B. Kwon,et al. 4-1BB (CD137) Is Required for Rapid Clearance of Listeria monocytogenes Infection , 2005, Infection and Immunity.
[8] K. Sugamura,et al. During Viral Infection of the Respiratory Tract, CD27, 4-1BB, and OX40 Collectively Determine Formation of CD8+ Memory T Cells and Their Capacity for Secondary Expansion1 , 2005, The Journal of Immunology.
[9] yang-xin fu,et al. Regulation of Follicular Dendritic Cell Networks by Activated T Cells: The Role of CD137 Signaling1 , 2005, The Journal of Immunology.
[10] B. Kwon,et al. Enhanced CD4 T Cell Responsiveness in the Absence of 4-1BB1 , 2005, The Journal of Immunology.
[11] M. Croft. The evolving crosstalk between co-stimulatory and co-inhibitory receptors: HVEM-BTLA. , 2005, Trends in immunology.
[12] B. Dörken,et al. Costimulation by CD137/4–1BB inhibits T cell apoptosis and induces Bcl‐xL and c‐FLIPshort via phosphatidylinositol 3‐kinase and AKT/protein kinase B , 2005, European journal of immunology.
[13] B. Kwon,et al. Stimulation with 4-1BB (CD137) inhibits chronic graft-versus-host disease by inducing activation-induced cell death of donor CD4+ T cells. , 2005, Blood.
[14] K. Pfeffer,et al. The role of herpesvirus entry mediator as a negative regulator of T cell-mediated responses. , 2005, The Journal of clinical investigation.
[15] Wenjun Ouyang,et al. A coreceptor interaction between the CD28 and TNF receptor family members B and T lymphocyte attenuator and herpesvirus entry mediator. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[16] A. Sharpe,et al. 4-1BB and OX40 Act Independently to Facilitate Robust CD8 and CD4 Recall Responses1 , 2004, The Journal of Immunology.
[17] Graham M Lord,et al. Recent developments in the transcriptional regulation of cytolytic effector cells , 2004, Nature Reviews Immunology.
[18] Hye-young Park,et al. 4-1BB-mediated immunotherapy of rheumatoid arthritis , 2004, Nature Medicine.
[19] J. Bae,et al. CD137-Deficient Mice Have Reduced NK/NKT Cell Numbers and Function, Are Resistant to Lipopolysaccharide-Induced Shock Syndromes, and Have Lower IL-4 Responses1 , 2004, The Journal of Immunology.
[20] Zihai Li,et al. 4-1BB and OX40 Dual Costimulation Synergistically Stimulate Primary Specific CD8 T Cells for Robust Effector Function1 , 2004, The Journal of Immunology.
[21] Aoshuang Chen,et al. The 4-1BB Costimulation Augments the Proliferation of CD4+CD25+ Regulatory T Cells1 , 2004, The Journal of Immunology.
[22] Lieping Chen. Co-inhibitory molecules of the B7–CD28 family in the control of T-cell immunity , 2004, Nature Reviews Immunology.
[23] M. Croft,et al. Costimulation of CD8 T Cell Responses by OX401 , 2004, The Journal of Immunology.
[24] P. Rogers,et al. The costimulation-regulated duration of PKB activation controls T cell longevity , 2004, Nature Immunology.
[25] E. Bertram,et al. A Switch in Costimulation from CD28 to 4-1BB during Primary versus Secondary CD8 T Cell Response to Influenza In Vivo1 , 2004, The Journal of Immunology.
[26] E. Wherry,et al. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells , 2003, Nature Immunology.
[27] I. Humphreys,et al. A Critical Role for OX40 in T Cell–mediated Immunopathology during Lung Viral Infection , 2003, The Journal of experimental medicine.
[28] D. Tough,et al. IL-15 Promotes the Survival of Naive and Memory Phenotype CD8+ T Cells , 2003, The Journal of Immunology.
[29] M. Croft. Co-stimulatory members of the TNFR family: keys to effective T-cell immunity? , 2003, Nature Reviews Immunology.
[30] J. Allison,et al. BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1 , 2003, Nature Immunology.
[31] M. McCausland,et al. CD137 costimulatory T cell receptor engagement reverses acute disease in lupus-prone NZB x NZW F1 mice. , 2003, The Journal of clinical investigation.
[32] D. Tough,et al. IL-15 Promotes the Survival of Naive and Memory Phenotype CD8+ T Cells1 , 2003, The Journal of Immunology.
[33] C. Takahashi,et al. Effector CD8 T cells possess suppressor function after 4-1BB and Toll-like receptor triggering , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[34] Rustom Antia,et al. Lineage relationship and protective immunity of memory CD8 T cell subsets , 2003, Nature Immunology.
[35] Urs Christen,et al. CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes , 2003, Nature.
[36] R. Ahmed,et al. Role of CD4 T Cell Help and Costimulation in CD8 T Cell Responses During Listeria monocytogenes Infection 1 , 2003, The Journal of Immunology.
[37] Susan M. Kaech,et al. Molecular and Functional Profiling of Memory CD8 T Cell Differentiation , 2002, Cell.
[38] Lieping Chen,et al. Costimulatory molecule-targeted antibody therapy of a spontaneous autoimmune disease , 2002, Nature Medicine.
[39] Sujung Park,et al. 4-1BB Promotes the Survival of CD8+ T Lymphocytes by Increasing Expression of Bcl-xL and Bfl-11 , 2002, The Journal of Immunology.
[40] Lieping Chen,et al. Signaling Through NK Cell-Associated CD137 Promotes Both Helper Function for CD8+ Cytolytic T Cells and Responsiveness to IL-2 But Not Cytolytic Activity1 , 2002, The Journal of Immunology.
[41] Z. Lee,et al. Immune Responses in 4-1BB (CD137)-Deficient Mice1 , 2002, The Journal of Immunology.
[42] Lieping Chen,et al. Cutting Edge: Expression of Functional CD137 Receptor by Dendritic Cells1 , 2002, The Journal of Immunology.
[43] E. Bertram,et al. Temporal Segregation of 4-1BB Versus CD28-Mediated Costimulation: 4-1BB Ligand Influences T Cell Numbers Late in the Primary Response and Regulates the Size of the T Cell Memory Response Following Influenza Infection1 , 2002, The Journal of Immunology.
[44] D. Richman,et al. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections , 2002, Nature Medicine.
[45] K. Takeda,et al. Expression and function of 4-1BB and 4-1BB ligand on murine dendritic cells. , 2002, International immunology.
[46] Aaron J. Johnson,et al. Provision of antigen and CD137 signaling breaks immunological ignorance, promoting regression of poorly immunogenic tumors. , 2002, The Journal of clinical investigation.
[47] Lieping Chen,et al. Administration of Agonistic Anti-4-1BB Monoclonal Antibody Leads to the Amelioration of Experimental Autoimmune Encephalomyelitis1 , 2002, The Journal of Immunology.
[48] G. Freeman,et al. The B7–CD28 superfamily , 2002, Nature Reviews Immunology.
[49] C. Maliszewski,et al. Ox40 Costimulation Enhances the Development of T Cell Responses Induced by Dendritic Cells In Vivo , 2002, The Journal of Immunology.
[50] C. Thompson,et al. T-cell regulation by CD28 and CTLA-4 , 2001, Nature Reviews Immunology.
[51] P. Rogers,et al. OX40 promotes Bcl-xL and Bcl-2 expression and is essential for long-term survival of CD4 T cells. , 2001, Immunity.
[52] M. Debenedette,et al. 4-1BB Ligand Induces Cell Division, Sustains Survival, and Enhances Effector Function of CD4 and CD8 T Cells with Similar Efficacy1 , 2001, The Journal of Immunology.
[53] A. Weinberg,et al. Therapeutic efficacy of OX-40 receptor antibody depends on tumor immunogenicity and anatomic site of tumor growth. , 2000, Cancer research.
[54] T. Noda,et al. Impairment of Antigen-Presenting Cell Function in Mice Lacking Expression of Ox40 Ligand , 2000, The Journal of experimental medicine.
[55] M. Bachmann,et al. OX40-deficient mice are defective in Th cell proliferation but are competent in generating B cell and CTL Responses after virus infection. , 1999, Immunity.
[56] G. Freeman,et al. Ox40-ligand has a critical costimulatory role in dendritic cell:T cell interactions. , 1999, Immunity.
[57] R. Mittler,et al. Anti–4-1bb Monoclonal Antibodies Abrogate T Cell–Dependent Humoral Immune Responses in Vivo through the Induction of Helper T Cell Anergy , 1999, The Journal of experimental medicine.
[58] R. Ahmed,et al. 4-1BB ligand, a member of the TNF family, is important for the generation of antiviral CD8 T cell responses. , 1999, Journal of immunology.
[59] D. A. Carlow,et al. A novel CD8 T cell-restricted CD45RB epitope shared by CD43 is differentially affected by glycosylation. , 1999, Journal of immunology.
[60] Lieping Chen,et al. NK1.1 cells express 4-1BB (CDw137) costimulatory molecule and are required for tumor immunity elicited by anti-4-1BB monoclonal antibodies. , 1998, Cellular immunology.
[61] S Oehen,et al. Differentiation of naive CTL to effector and memory CTL: correlation of effector function with phenotype and cell division. , 1998, Journal of immunology.
[62] S. Kim,et al. Human 4-1BB (CD137) signals are mediated by TRAF2 and activate nuclear factor-kappa B. , 1998, Biochemical and biophysical research communications.
[63] C. Thompson,et al. 4-1BB and Ox40 Are Members of a Tumor Necrosis Factor (TNF)-Nerve Growth Factor Receptor Subfamily That Bind TNF Receptor-Associated Factors and Activate Nuclear Factor κB , 1998, Molecular and Cellular Biology.
[64] M. Rep,et al. Phenotypic and Functional Separation of Memory and Effector Human CD8+ T Cells , 1997, The Journal of experimental medicine.
[65] A. Aruffo,et al. 4-1BB Costimulatory Signals Preferentially Induce CD8+ T Cell Proliferation and Lead to the Amplification In Vivo of Cytotoxic T Cell Responses , 1997, The Journal of experimental medicine.
[66] Lieping Chen,et al. Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors , 1997, Nature Medicine.
[67] J. Bonner,et al. Differentiation , 1968, Nature.
[68] C. Ware,et al. B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator , 2005, Nature Immunology.
[69] T. Watts,et al. TNF/TNFR family members in costimulation of T cell responses. , 2005, Annual review of immunology.
[70] C. Ware. Network communications: lymphotoxins, LIGHT, and TNF. , 2005, Annual review of immunology.
[71] J. Altman,et al. In vivo stimulation of CD137 broadens primary antiviral CD8+ T cell responses , 2002, Nature Immunology.